Table 2.
Recent major series of allogeneic stem cell transplant (ASCT) trials for myelofibrosis
*Group 1, GVHD prophylaxis cyclosporine A + mycophenolate moffetil ± methotrexate; Group 2, GVHD prophylaxis tacrolimus/sirolimus ± methotrexate.
Recent major series of allogeneic stem cell transplant (ASCT) trials for myelofibrosis
*Group 1, GVHD prophylaxis cyclosporine A + mycophenolate moffetil ± methotrexate; Group 2, GVHD prophylaxis tacrolimus/sirolimus ± methotrexate.
